ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Large Studies Show Promising Results For Targeted Therapies Alimta, Tarceva

June 26, 2009

Computer Learning May Help Women In Treatment Decision

October 30, 2009

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

STAR Begins: Critics of Trial Call For Including A Placebo Arm

June 4, 1999

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013